chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient developed rash one day after vaccines administered. Rash consistent with erythema multiforme.
Within 3 days, and continuing presently:  Angry, belligerent outbursts lasting up to 20 minutes per episode / 3 or 4 times per day (totally out of character--never seen before); fixation on lights; extreme difficulty focusing; repetitive and stimulating behavior; OCD behaviors; inappropriate playing with toys (lining up toys); must hold an item at all times; crying/sad moods (not seen before); often mixing up words in sentence (not seen before).  Within 10 days:  facial rash which lasted 4 weeks.
Woke up on 12-4-09 with mild headache.  Went running and after she returned home both feet on the bottom had a tingling sensation going on all day.
Cough, Headache, Sore Throat, Weak, Unable to sleep, and Acid reflux starting around 2 am the morning after vaccines were given
discomfort with injection; Vaccine is painful; This literature marketed report was received from the bellow authors and refers to 13 adults patients of unspecofied age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not provided.  The study was conducted among both male and female, from 18 to 64 year old ,  undergraduate and graduate students at a large public university , they were selected as the study participants because of their constant exposure to the internet and technology. Quantitative data on the survey included questions that asked about  demographic characteristics, sexual health behaviors, knowledge of HPV, barriers to HPV uptake, and digital health technology practices.  Because of the descriptive nature of the survey, no inclusion and exclusion criteria were established. The survey was implemented using online software. Before data collection, the survey was pilot tested with a sample of undergraduate and graduate students (n = 81). Feedback provided from this sample was used to revise the survey for data collection, which was conducted over a period of 6 months.  On an unknown date, the patients were vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) for prophylaxis or quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine(GARDASIL) unidentified Merck hpv vaccine administered (name and lot number not provided) (dosage, frequency and route were not provided).  It was stated that one of the barriers to human pápillomavirus uptake was that the vaccin was painful and the discomfort with th einjection.  The outcome of the events were unknown.
1 y o female had a flu shot on 12/28/11. The next day she couldn't bear weight on her legs or roll over. Nine days later parents had the child evaluated. Lower extremity weakness was noted but DTR's were present. Neurologist eval the following week. Dx GBS - resolving.
Patient with history of roux-en Y gastric bypass, 35 year old, experienced symptoms of hypoglycemia necessitating surgical management of hr noninsulionoma pancreatogenous hypoglycemia with a distal panoreatectomy and splenectomy.  Post-operatively patient received influenza vaccine and pneumococcal vaccine in the right deltoid on 1/30/2007.  Patient reacted with a cellulitis like reactions. Cultures are currently pending and patient continued to have febrile spikes.
Fever on day following injection which subsided within 24 hours, then on May 6, left arm broke out in hives.
nurses at their office may have given a YF-Vax to a patient that was reconstituted with sterile water, not sodium chloride as is directed with no reported adverse event; Initial information received on 29-Nov-2022 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves patient of unknown demographics and it was reported that nurses at their office may have given a yf-vax(YELLOW FEVER VACCINE - ) to a patient that was reconstituted with sterile water, not sodium chloride as is directed with no reported adverse event  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received an unknown dose of suspect YELLOW FEVER VACCINE - (formulation, strength: unknown) lot UJ683AA, expiration date:15-Sep-2023 via unknown route in unknown administration site as Immunization.  On an unknown date the nurses at their office may have given a Yf-vax to a patient that was reconstituted with sterile water, not sodium chloride as is directed with no reported adverse event (product preparation error) (unknown latency) following the administration of YELLOW FEVER VACCINE -.  It was unknown to the reporter if a dose of Yf-Vax was given with the incorrect diluent; that at this time all was known was that there was an extra remaining diluent and no Yf-Vax; that the reason for the extra diluent was thought to be due to an incorrect diluent was used with the vaccine; that further research needs to be done.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event (nurses at their office may have given a YF-Vax to a patient that was reconstituted with sterile water, not sodium chloride as is directed with no reported adverse event).  At time of reporting, the outcome was Unknown for the event   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
I am 31 weeks pregnant with my second child, a boy, due November 6.   At 10:00 PM on Sep 10, 13 hours after the vaccine was administered, I began noticing an episodic pinching feeling in my heart. It was unsettling and difficult to sleep. I counted 16 occurrences. The next day, Sep 11, the episodic 'pinching' had stopped but I felt a mild pressure in my chest for most of the day. I eventually called my friend who is a cardiologist and she asked several questions and had me lean forward, which did work to resolve the pressure. The fetus was kicking and moving normally, and I had no other signs or symptoms of distress or illness. She said it could be a case of Pericarditis, and I considered going to L&D to be checked out, however by 8:00 PM, the pressure sensation had disappeared. I have been fine ever since.
Chills and fever - not sure this was from vaccine, but have had no problems for months. Soreness in arm, which I expected.
received an expired dose of Menactra, with no reported adverse event; Initial information was received on 04-Mar-2022 regarding an unsolicited valid non-serious case received from other health professional via call center.  This case involves a 13years old male patient who received an expired dose of menactra, with no reported adverse event after receiving vaccine Meningococcal A-C-Y-W135 (D CONJ) Vaccine [Menactra].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HPV Vaccine (HPV Vaccine) and Diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (TDAP) as Prophylactic vaccination.  On 03-Mar-2022, the patient received a dose of suspect Meningococcal A-C-Y-W135 (D CONJ) Vaccine (formulation, strength: unknown) at a dose of 0.5 ml once (batch number: U6877BA; expiration date: 28-Feb-2022) via intramuscular route in left arm  for immunization.  On 03-Mar-2022, the patient received an expired dose of menactra, with no reported adverse event (expired product administered) (latency: same day) following the administration of Meningococcal A-C-Y-W135 (D CONJ) Vaccine.  Action Taken: not applicable  At time of reporting, the outcome was Unknown for the event (expired product administered).  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
This case was reported by a nurse and described the occurrence of limited range of motion in arm in a 50 year old female subject who was vaccinated with influenza virus vaccine for prophylaxis. There were no concurrent medications. On 11/04/05 the subject received 1st dose of Fluarix in the left arm. On 11/04/05, less than one day after vaccination with Fluarix, the subject experienced limited range of motion in the left arm. At the time of initial reporting, 11/29/05, the outcome of the event was not provided. The nurse considered the event to possibly be related to vaccination with Fluarix.
1 hour after receiving the shot, I started to breakout in a widespread rash with hives and inflammation. I also had muscle soreness in my left arm and shoulders. Muscle soreness lasted a few days. I took benadryl and zrtec for the rash and hives. The rash disappeared after 3-4 days, but the hives continued for about a week. The itching lasted 11 days.
This case was reported by a healthcare professional and described the occurrence of local reaction in a 75 year old male subject who was vaccinated with Twinrix for prophylaxis. On an unspecified date in 2004, the subject received the first and only dose of Twinrix (1ml, unknown). On an unspecified date(s) in 2004, at an unspecified time after vaccination with Twinrix, the subject experienced a local reaction at the injection site that was red, swollen and tender. The subject reported that the events were severe. The immunization series was discontinued.  On an unspecified date(s) in 2004, the events were resolved. The healthcare professional considered the events were probably related to vaccination with Twinrix.
Pt developed stomache ache 1-2 days after injection and a rash from her shoulder to her elbow with itching 3-4 days after her inj. that lasted about 5 days.
numbness in fingers/hands/feet approximately 3 weeks post flu shot.  Diagnosed with GBS.  4/27/09 Received hospital medical records of 11/24-12/1/2008. FINAL DX: Guillain-Barre; possible neurogenic bladder; e. cole UTI Records reveal patient experienced rapid onset of progressive weakness of LEs & UEs.  Had been out of the country x 3 wks & during return flight home developed HA, hand weakness, difficulty walking, numbness of feet, balance difficulty, pain of upper back, glutes & thighs .  Neuro consult done.  Reflexes diminished.  LP done & tx w/IVIG x 5 days w/some improvement.  Had neurogenic bladder requiring Foley cath.  Had continued neuropathic pain of right side.  Improved slowly & d/c to inpatient rehab.
Report an adverse event from a patient who received the 2 doses of Moderna Covid-19 vaccine; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION COMPLICATION (Report an adverse event from a patient who received the 2 doses of Moderna Covid-19 vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Report an adverse event from a patient who received the 2 doses of Moderna Covid-19 vaccine). At the time of the report, VACCINATION COMPLICATION (Report an adverse event from a patient who received the 2 doses of Moderna Covid-19 vaccine) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications and treatment information was not provided. nurse called back to report an adverse event from a patient who received the 2 doses of the Moderna Covid-19 vaccine, but after to provided the old case number the communication was interrupted and because the consent for a follow-up call was not granted, agent did not call back the nurse.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Non significant Follow up received om 26-MAY-2021 Contains NNI
This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MYOCARDIAL INFARCTION (medically significant), outcome "unknown", described as "heart attack". Additional information: Patient had no prior histories of heart attack problems. These spike proteins are firing throughout the human body. Reporter said how can that possibly be healthy or good. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Received the first shot in my left arm.  Started with bad shoulder pain and couldn't lay on my left side a few days after the shot once the soreness subsided.  The pain got worse so I saw my primary and he thought I might have a rotator cuff issue and to get the second shot in my right arm.   the left got significantly worse and red (even though the second shot was given in the right arm) and there was burning down my arm.  The pain was so bad I had to go to the ER twice and urgent care to get help with the pain and because the arm was very red and warm to the touch and felt like a burning pain down my arm.  I had ultrasound and xrays on my shoulder and chest and all looked normal.  Doctors thought I had a pinched nerve in neck and received an MRI which ruled that out.  Can no longer lift my arm and orthopedic doctor diagnosed my condition as frozen shoulder and barachial neuritis (I will be getting an MRI of my shoulder and EMG to confirm).  All caused by how the shot was administered in my left arm.  I am in terrible pain everyday and need to go to physcial therapy 3 times a week for the next year to get movement back in my arm.
Constant ringing in both ears since the day of the injection.  It does seem louder on day5 then it had been.  I have not tried to treat.
Patient started displaying symptoms of anaphylaxis (difficulty breathing) approx. 5 minutes after administration of vaccination. Administered Epipen jr, while calling EMS. Breathing normalized after epinephrine was given. Monitored patient until paramedics arrived. She was take to ED as a precaution and discharged with steroid rx.
The vaccine triggered severe and debilitating hemiplegic migraines that left me immobile and unable to work. I had to receive medication through IV before my symptoms resolved. I was seen at the local Medical Center on 3/26/21 for this medication. I had the exact same reaction to the second vaccination, and I visited an urgent care to receive the same medications through shots.
Patient felt dizzy soon after vaccination. She was nervous tired in eyes, no chest pain, SOB, headache, n/v, gait problems. Patient drinking water , deferred crackers. Lungs clear, heart regular. Feeling better right now, ready to leave .  She often has similar episodes  when giving blood.
Fever over 102F, chills, lethargy/fatigue, body aches, headache, nausea worse than January COVID case
We did not realize it was a reaction till 3rd vaccine 3/22/05. 12/24/04: Right before vacation, no cold symptoms. Just ear aches. All vacation 17 days. Went to see doctor on a Friday, severe ear ache left ear. Prescribed drops. 3/19/05: Felt like everything cleared up and finally felt like myself. First time since December. 3/22/05: Third hepatitis B approximately 4:15 PM. Came back to switchboard and about and started having pains in my heart area. Thought nothing about the vaccine. The pains continued until 10 PM. Ears also returned and vision blurred. Call the doctor. 3/24/05: Ears/eyes blood shot. Asked for a phone call, for I see a hospice patient as a volunteer. Might be conjunctivitis. Cancelled visit. 3/25/05: Eyes blood shot, ears ache. 3/29/05: Not feeling well. Gave me incident report and to watch. Rash-like raised pimples; tiny on only right hand, swelling by knuckles. Put cold compresses on site. 3/30/05: Rash gone. Ears have not cleared since third vaccine. 3/30/05: Heart pain, not feeling well at all, no appetite. Afternoon, no pain; just aching in left side. Just don't feel right. 3/31/05: Called into work. Stayed home; put ear drops, vision blurred and just did not feel good. Slept most of day. 4/1/05: Went to see doctor. He explained since the first symptoms took six weeks to clear. This time it actually could be double the time to clear of all the symptoms. He said I should make an appointment if I continue to have chest pains. 4/2/05 - 4/11/05: Ears still congested, fluid. Vision is still burred. Heart OK. I noticed that I am really more tired than normal. I am not one to ever take naps or lay down during the day. Sometime I just cannot stay up.
An 18 year old female, with no reported history of allergies,  presented to store on May 3, 2021 for her second COVID-19 vaccine. Approximately 24 hours after vaccination, she developed a headache. Approximately 48 hours after vaccination, she developed a rash that  spread from the neck to the legs. She went to Hospital Emergency Room. In the ER she was given Banophen (Benadryl) and famotidine. Later that same day, the symptoms resolved. At approximately 9am on May 5, 2021, the rash returned and spread to the palms of the hands and the face. At approximately 11:20 am, the patient took Banophen and famotidine. She called the pharmacy around noon for advise, as the rash was still present. Patient was advised to call her primary care physician.
Information has been received from a physician concerning an adolescent female, who on 08-FEB-2007 was vaccinated with her first dose of Gardasil, IM.  Subsequently, on an unknown date, she went to her physician for her second vaccination; but the physician postponed the dose because the patient had a migraine and not feeling well.  On 31-MAY-2007 the patient received her second dose, which was later than the indicated time-period.  No further information is available.
This spontaneous report was received from a health care worker refers to unspecified number of patients of unknown age and gender. Past medical history and concurrent conditions were not reported. The health care worker reported that, the patients were vaccinated with improperly stored doses PNEUMOVAX 23 (lot, batch # K020800, expiry date 05-JUN-2016, dose, strength, dose number, vaccination site, route of administration unspecified) since her initial call on 29-OCT-2015. Concomitant medications were not provided. No adverse events were reported. No further information was provided. Product quality complaint (PQC) was not reported. Additional information has been requested.
a lot of swelling, itching and rash; a lot of swelling, itching and rash; "now a pimple is coming into the rash"; a lot of swelling, itching and rash; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (a lot of swelling, itching and rash), PRURITUS (a lot of swelling, itching and rash), DERMATITIS ACNEIFORM ("now a pimple is coming into the rash") and RASH (a lot of swelling, itching and rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Dec-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2021, the patient experienced SWELLING (a lot of swelling, itching and rash), PRURITUS (a lot of swelling, itching and rash), DERMATITIS ACNEIFORM ("now a pimple is coming into the rash") and RASH (a lot of swelling, itching and rash). At the time of the report, SWELLING (a lot of swelling, itching and rash), PRURITUS (a lot of swelling, itching and rash), DERMATITIS ACNEIFORM ("now a pimple is coming into the rash") and RASH (a lot of swelling, itching and rash) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  Treatment information was not provided.
Pt developed fatigue, chills, ? fever (felt warm), body aches on 10/29/13. Pt observed to have large area of inflammation - swelling, redness, increased warmth and itchy at injection site on 10/30/13 (approx 2" x 2").
Left arm sore, body pain on left side from neck till bottom of foot,  middle-upper of back and lower mid back,  feel really cold, fever 99.6 but, now it?s gone down to 98.2 after I took a Tylenol rapid release pill, chest tight but, I have uncontrolled asthma took my Albuterol and Symbicort inhaler.
OSTEOARTHRITIS/INCREASED OSTEOARTHRITIC; COVID VACCINE ISSUE/SORE ARM; This spontaneous case was reported by a patient and describes the occurrence of OSTEOARTHRITIS (OSTEOARTHRITIS/INCREASED OSTEOARTHRITIC) and VACCINATION SITE PAIN (COVID VACCINE ISSUE/SORE ARM) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) for Rheumatoid arthritis.    Concurrent medical conditions included Rheumatoid arthritis.   In 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started UPADACITINIB (RINVOQ) (Oral) at an unspecified dose. On an unknown date, the patient experienced OSTEOARTHRITIS (OSTEOARTHRITIS/INCREASED OSTEOARTHRITIC) and VACCINATION SITE PAIN (COVID VACCINE ISSUE/SORE ARM). At the time of the report, OSTEOARTHRITIS (OSTEOARTHRITIS/INCREASED OSTEOARTHRITIC) and VACCINATION SITE PAIN (COVID VACCINE ISSUE/SORE ARM) outcome was unknown.            No concomitant medications were reported.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  No treatment medications were reported.  The reporter's causality for the event(s) of osteoarthritis/increased osteoarthritic and COVID vaccine issue/sore arm with Rinvoq (upadacitinib) was not provided, while assessed COVID vaccine issue/sore arm as possibly related with Moderna COVID-19 vaccine.
on July 17th of 2018 patient was given her routine shots.  a week after recieving the vaccines patient  became very ill with a really bad stomach virus called gastroenteritis.gastroenteritis ended up turning into intussusception virus. Patient was diagnosed with sepsis, and organ failure.
A few hours after receiving vaccine, I had throbbing headache, Temp. 103, fever , chills, body ache. That subsided after 3 days. Now it is over 1 month later and I am still very tired, my joints seem to ache more than usual, left arm hurts most of the time ( joints and muscles), and injection sight still itches. I am hoping that these symptoms go away before my next check up at Dr. office on May 27. If not, I may have to have him do some blood tests to see what's going on.
Found by father not breathing approximately 0500 on 1/10.  Attempted resuscitation at home via police then EMS.  To hospital with resuscitation efforts for approximately 1 hr with no results.